ArticleBasic research in cardiology2016

Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages.

Mitchel Tate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.